miR-10b, miR-26a, miR-146a And miR-153 Expression in Triple Negative Vs Non Triple Negative Breast Cancer: Potential Biomarkers

MicroRNA-214 acts as a potential oncogene in breast cancer by targeting the PTEN-PI3K/Akt signaling pathway

(2016) FANG WANG et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

The complexity of microRNAs in human cancer

(2016) Jennifer Y. Y. Kwan et al.   JOURNAL OF RADIATION RESEARCH

Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF-κB signals

(2016) Zhuo-Jia Chen et al.   Molecular Oncology

Overexpression of SphK1 enhances cell proliferation and invasion in triple-negative breast cancer via the PI3K/AKT signaling pathway

(2016) Jun Li et al.   TUMOR BIOLOGY

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer

(2016) Jingdan Qiu et al.   Journal of Cancer

ERβ1 inversely correlates with PTEN/PI3K/AKT pathway and predicts a favorable prognosis in triple-negative breast cancer

(2015) Jin Wang et al.   BREAST CANCER RESEARCH AND TREATMENT

miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer

(2015) Peng Liu et al.   CANCER LETTERS

Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer

(2015) Nami Yamashita et al.   Clinical Breast Cancer

microRNA-26a suppresses recruitment of macrophages by down-regulating macrophage colony-stimulating factor expression through the PI3K/Akt pathway in hepatocellular carcinoma

(2015) Zong-Tao Chai et al.   Journal of Hematology & Oncology

Altered microRNA Expression Profile in Synovial Fluid from Patients with Knee Osteoarthritis with Treatment of Hyaluronic Acid

(2015) Ji-Feng Xu et al.   Molecular Diagnosis & Therapy

Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers

(2015) Insaf Fkih M’hamed et al.   CELLULAR ONCOLOGY

Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients

(2015) Isabel Stückrath et al.   Oncotarget

Association of BRCA1 promoter methylation with sporadic breast cancers: Evidence from 40 studies

(2015) Li Zhang et al.   Scientific Reports

Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer

(2015) Paolo Cossu-Rocca et al.   PLoS One

Doubling Down on the PI3K-AKT-mTOR Pathway Enhances the Antitumor Efficacy of PARP Inhibitor in Triple Negative Breast Cancer Model beyond BRCA-ness

(2015) Pradip De et al.   NEOPLASIA

MicroRNAs as regulatory elements in triple negative breast cancer

(2014) Melina-Theoni Gyparaki et al.   CANCER LETTERS

BRCA1 regulation of epidermal growth factor receptor (EGFR) expression in human breast cancer cells involves microRNA-146a and is critical for its tumor suppressor function

(2014) E Kumaraswamy et al.   ONCOGENE

Statin induces inhibition of triple negative breast cancer (TNBC) cells via PI3K pathway

(2013) Yeon Hee Park et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Association of BRCA1 germline mutations in young onset triple-negative breast cancer (TNBC)

(2013) R. Andrés et al.   Clinical & Translational Oncology

MicroRNAs and Triple Negative Breast Cancer

(2013) Elvira D'Ippolito et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Downregulation of miR-223 and miR-153 mediates mechanical stretch-stimulated proliferation of venous smooth muscle cells via activation of the insulin-like growth factor-1 receptor

(2012) Lei Song et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers

(2012) Weijie Chen et al.   TUMOR BIOLOGY

Triple-negative breast cancer: are we making headway at least?

(2012) Monica Arnedos et al.   Therapeutic Advances in Medical Oncology

Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFκB pathway

(2011) Miljana Tanic et al.   BREAST CANCER RESEARCH AND TREATMENT

Curcumin Analogue CDF Inhibits Pancreatic Tumor Growth by Switching on Suppressor microRNAs and Attenuating EZH2 Expression

(2011) B. Bao et al.   CANCER RESEARCH

Down-regulation ofBRCA1expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers

(2011) Amandine I. Garcia et al.   EMBO Molecular Medicine

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

(2011) Brian D. Lehmann et al.   JOURNAL OF CLINICAL INVESTIGATION

MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis

(2011) Kohei Nakata et al.   SURGERY

Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells

(2008) D Bhaumik et al.   ONCOGENE